Position in LLY
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$43,191,477
+$16,389,380 QoQ
Shares Held
36,010
+23.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.37%
of 13F equity value
Holder Rank
#586
of 4,604 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Covea Finance holds $67,956,643 across 2 Drug Manufacturers - General names. LLY ranks #1 (63.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
36,010 | $43,191,477 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
196,020 | $24,765,166 |
All Filings in LLY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,191,477 | 36,010 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $26,802,097 | 29,140 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $33,282,842 | 30,970 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $30,573,410 | 40,070 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $34,665,699 | 44,470 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $25,685,801 | 31,100 | Shares | Sole | 2025-04-22 | |
| No filing history on record for this holder in this stock. | ||||||